Literature DB >> 25111024

Characterization of an RNA aptamer against HPV-16 L1 virus-like particles.

Ana Gabriela Leija-Montoya1, María Luisa Benítez-Hess, Julia Dolores Toscano-Garibay, Luis Marat Alvarez-Salas.   

Abstract

The human papillomavirus (HPV) capsid is mainly composed of the L1 protein that can self-assemble into virus-like particles (VLPs) that are structurally and immunologically similar to the infectious virions. We report here the characterization of RNA aptamers that recognize baculovirus-produced HPV-16 L1 VLPs. Interaction and slot-blot binding assays showed that all isolated aptamers efficiently bound HPV-16 VLPs, although the Sc5-c3 aptamer showed the highest specificity and affinity (Kd=0.05 pM). Sc5-c3 secondary structure consisted of a hairpin with a symmetric bubble and an unstructured 3'end. Biochemical and genetic analyses showed that the Sc5-c3 main loop is directly involved on VLPs binding. In particular, binding specificity appeared mediated by five non-consecutive nucleotide positions. Experiments using bacterial-produced HPV-16 L1 resulted in low Sc5-c3 binding, suggesting that recognition of HPV-16 L1 VLPs relies on quaternary structure features not present in bacteria-produced L1 protein. Sc5-c3 produced specific and stable binding to HPV-16 L1 VLPs even in biofluid protein mixes and thus it may provide a potential diagnostic tool for active HPV infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25111024      PMCID: PMC4162430          DOI: 10.1089/nat.2013.0469

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  49 in total

1.  An efficient RNA aptamer against human influenza B virus hemagglutinin.

Authors:  Subash C B Gopinath; Yuriko Sakamaki; Kazunori Kawasaki; Penmetcha K R Kumar
Journal:  J Biochem       Date:  2006-05       Impact factor: 3.387

Review 2.  Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes.

Authors:  Y-F Xu; Y-Q Zhang; X-M Xu; G-X Song
Journal:  Arch Virol       Date:  2006-06-22       Impact factor: 2.574

3.  Combinatorial selection of a RNA thioaptamer that binds to Venezuelan equine encephalitis virus capsid protein.

Authors:  Jonghoon Kang; Myung Soog Lee; Stanley J Watowich; David G Gorenstein
Journal:  FEBS Lett       Date:  2007-05-04       Impact factor: 4.124

Review 4.  Nucleic acids as therapeutic agents.

Authors:  Luis M Alvarez-Salas
Journal:  Curr Top Med Chem       Date:  2008       Impact factor: 3.295

5.  Neutralization of infectivity of porcine circovirus type 2 (PCV2) by capsid-binding 2'F-RNA aptamers.

Authors:  Sorah Yoon; Garam Lee; Dongun Han; Jae-Young Song; Kyung-Sun Kang; Yong-Soon Lee
Journal:  Antiviral Res       Date:  2010-07-06       Impact factor: 5.970

6.  Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs.

Authors:  Latifa Bousarghin; Antoine Touze; Guillaume Gaud; Sophie Iochmann; Eva Alvarez; Pascale Reverdiau; Julien Gaitan; Marie-Lise Jourdan; Pierre-Yves Sizaret; Pierre L Coursaget
Journal:  Mol Cancer Ther       Date:  2009-01-27       Impact factor: 6.261

7.  An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins: N- and C-terminal fusion of GFP to the L1 and L2 capsid proteins.

Authors:  Oliver P Windram; Brandon Weber; Mohamed A Jaffer; Edward P Rybicki; Dionne N Shepherd; Arvind Varsani
Journal:  Arch Virol       Date:  2008-01-04       Impact factor: 2.574

8.  Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate.

Authors:  Maren Knappe; Sabrina Bodevin; Hans-Christoph Selinka; Dorothe Spillmann; Rolf E Streeck; Xiaojiang S Chen; Ulf Lindahl; Martin Sapp
Journal:  J Biol Chem       Date:  2007-07-18       Impact factor: 5.157

Review 9.  Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix].

Authors:  Susan J Keam; Diane M Harper
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Structure-based engineering of papillomavirus major capsid l1: controlling particle assembly.

Authors:  Brooke Bishop; Jhimli Dasgupta; Xiaojiang S Chen
Journal:  Virol J       Date:  2007-01-08       Impact factor: 4.099

View more
  6 in total

Review 1.  Aptamer-based biosensors for virus protein detection.

Authors:  Beibei Lou; Yanfei Liu; Meilin Shi; Jun Chen; Ke Li; Yifu Tan; Liwei Chen; Yuwei Wu; Ting Wang; Xiaoqin Liu; Ting Jiang; Dongming Peng; Zhenbao Liu
Journal:  Trends Analyt Chem       Date:  2022-07-19       Impact factor: 14.908

Review 2.  Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses.

Authors:  Víctor M González; M Elena Martín; Gerónimo Fernández; Ana García-Sacristán
Journal:  Pharmaceuticals (Basel)       Date:  2016-12-16

Review 3.  Application of Aptamers in Virus Detection and Antiviral Therapy.

Authors:  Xinran Zou; Jing Wu; Jiaqi Gu; Li Shen; Lingxiang Mao
Journal:  Front Microbiol       Date:  2019-07-03       Impact factor: 5.640

Review 4.  Aptamers for Anti-Viral Therapeutics and Diagnostics.

Authors:  Tae-Hyeong Kim; Seong-Wook Lee
Journal:  Int J Mol Sci       Date:  2021-04-17       Impact factor: 5.923

Review 5.  Aptamers in Virology-A Consolidated Review of the Most Recent Advancements in Diagnosis and Therapy.

Authors:  Tejabhiram Yadavalli; Ipsita Volety; Deepak Shukla
Journal:  Pharmaceutics       Date:  2021-10-09       Impact factor: 6.321

Review 6.  Oligonucleotide aptamers for pathogen detection and infectious disease control.

Authors:  Quanyuan Wan; Xiaohui Liu; Youli Zu
Journal:  Theranostics       Date:  2021-08-27       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.